Book Reviews : Environment and Health: The European Charter and Commentary World Health Organisation, Regional Office for Europe, Copenhagen, 1990 154 pp.; SFr. 26.- / £ 10.50 ISBN 92-890-1126-2

1992 ◽  
Vol 1 (2) ◽  
pp. 127-127
Author(s):  
F.W. Lunau
2019 ◽  
Vol 98 (5) ◽  
pp. 473-477 ◽  
Author(s):  
Irina A. Pogonysheva ◽  
D. A. Pogonyshev

EU countries have accumulated a considerable amount of scientific research demonstrating the influence of a number of environmental factors on human health. The paper reviews European research on the relation between the environment and human health. The authors present a review of normative and non-governmental initiatives in the field of environmental control and human health in the European region, major environmental causes of human health deterioration and initiatives aiming at preventing ecology-dependant health issues. In 1989 World Health Organisation (WHO) held the First Ministerial Conference on Environment and Health that kickstarted the process uniting the healthcare field and the field of environmental protection. The main objective of the “Environment and Health” Process is to mitigate major environmental risks for human health. The objective is to be achieved through regular Ministerial Conferences held every five years by the World Health Organisation Regional Office. According to the policy stated in “Health-2020”, ecology is an important factor for maintaining good human health and establishment of sustainable communities and favorable environment should be prioritized in the European region of WHO. According to the research presented by WHO, major environmental causes of increased disease rate are atmospheric pollutants, accumulation of heavy metal leads and other harmful chemicals in the environment, climate change, noise pollution, low quality of drinking water and poor hygienic conditions. The review presents a consideration of recommendations given in “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement”, Scopus, Web of Science, eLIBRARY.RU, CyberLeninka, and other scientific databases were used for this review.


2017 ◽  
Vol 6 (2) ◽  
Author(s):  
Heidi Albert ◽  
Andre Trollip ◽  
Donatelle Erni ◽  
Kekeletso Kao

Background: Quality-assured tuberculosis laboratory services are critical to achieve global and national goals for tuberculosis prevention and care. Implementation of a quality management system (QMS) in laboratories leads to improved quality of diagnostic tests and better patient care. The Strengthening Laboratory Management Toward Accreditation (SLMTA) programme has led to measurable improvements in the QMS of clinical laboratories. However, progress in tuberculosis laboratories has been slower, which may be attributed to the need for a structured tuberculosis-specific approach to implementing QMS. We describe the development and early implementation of the Strengthening Tuberculosis Laboratory Management Toward Accreditation (TB SLMTA) programme.Development: The TB SLMTA curriculum was developed by customizing the SLMTA curriculum to include specific tools, job aids and supplementary materials specific to the tuberculosis laboratory. The TB SLMTA Harmonized Checklist was developed from the World Health Organisation Regional Office for Africa Stepwise Laboratory Quality Improvement Process Towards Accreditation checklist, and incorporated tuberculosis-specific requirements from the Global Laboratory Initiative Stepwise Process Towards Tuberculosis Laboratory Accreditation online tool.Implementation: Four regional training-of-trainers workshops have been conducted since 2013. The TB SLMTA programme has been rolled out in 37 tuberculosis laboratories in 10 countries using the Workshop approach in 32 laboratories in five countries and the Facility based approach in five tuberculosis laboratories in five countries.Conclusion: Lessons learnt from early implementation of TB SLMTA suggest that a structured training and mentoring programme can build a foundation towards further quality improvement in tuberculosis laboratories. Structured mentoring, and institutionalisation of QMS into country programmes, is needed to support tuberculosis laboratories to achieve accreditation.


2004 ◽  
Vol 9 (4) ◽  
pp. 3-4 ◽  
Author(s):  
J. S. Spika ◽  
F X Hanon ◽  
S Wassilak ◽  
R G Pebody ◽  
N Emiroglu

The World Health Organisation (WHO) Regional Office for Europe has recently published a strategic plan and surveillance guidelines for measles and congenital rubella infection. The strategy prioritises measles control activities but encourages the introduction of rubella vaccine when measles vaccine coverage has reached >90 %; although, many western European countries with suboptimal measles vaccine coverage are already using the combined measles, mumps and rubella (MMR) vaccine. Women in these countries may have an especially high risk of having an infant with congenital rubella syndrome. WHO is seeking to improve the surveillance for rubella and congenital rubella syndrome as a means to obtain better information on the burden of these diseases and engage policy decision makers in the need to support the WHO European Region's strategies for rubella.


Sign in / Sign up

Export Citation Format

Share Document